Clinical Trial Update: OptiVol for Precision Medical Management of Heart Failure [NA]

View source ↗

Summary

The OptiVol trial for precision medical management of heart failure was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy
• Nonischemic Cardiomyopathy

Snippet

Sponsor: University of Rochester | Conditions: Ischemic and Non-ischemic Cardiomyopathy | NA | Status: TERMINATED | Results posted: 2025-06-06